Enclosed herewith Outcome of the Board Meeting held on May 30,2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evexia Lifecare's board met on May 30, 2025 (8:00 PM to 10:00 PM) and approved the audited financial results, both standalone and consolidated, for the quarter and full financial year ended March 31, 2025. The board also appointed Ms. Krupalibahen Rajeshbhai Mehta (DIN: 11109785) as an Additional Non-Executive Independent Director for a 5-year term, subject to shareholder approval. Ms. Mehta has an academic background in Sanskrit, is not related to any director, KMP, or promoter, and holds no shares in the company. Importantly, the auditor's report on the financial results is a qualified report, and the company has attached a Statement on Impact of Audit Qualifications as required. No other director or KMP changes were disclosed in this filing.
The appointment of a new independent director is a routine governance update, but the qualified audit report is a notable flag for shareholders as it indicates the auditor raised concerns or qualifications on certain aspects of the financials — investors should review the Statement on Impact of Audit Qualifications for details. Overall, this filing combines routine annual results approval with a governance caveat worth monitoring.